Sandra Sanabria Bohórquez

89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

Frederike Bensch, Elly L. van der Veen, Marjolijn N. Lub–de Hooge et al. · Nature Medicine · 2018 · 734 citations · Full text

Medicine, Oncology, Pharmacology +17

[ ¹⁸ F]MK-9470, a positron emission tomography (PET) tracer for <i>in vivo</i> human PET brain imaging of the cannabinoid-1 receptor

H. Donald Burns, Koen Van Laere, Sandra Sanabria Bohórquez et al. · Proceedings of the National Academy of Sciences · 2007 · 315 citations · Full text

Medicine, Neuroscience, Pharmacology +9

Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease

Susanne Ostrowitzki, Tobias Bittner, Kaycee M. Sink et al. · JAMA Neurology · 2022 · 224 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake

Carol Addy, Hamish Wright, Koen Van Laere et al. · Cell Metabolism · 2008 · 200 citations · Full text

Life Sciences, Nutritional Sciences, Pharmacology +14

Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease

Edmond Teng, Paul T. Manser, Karen Pickthorn et al. · JAMA Neurology · 2022 · 191 citations · Full text

Life Sciences, Neurology, Neuroscience +17